Teva Pharmaceutical Industries, the No.1 source of generic drugs in the US, said on Monday that it would acquire the Ivax Corp for about US$7.4 billion in a bid to become the world's largest maker of lower-cost drugs.
The deal will allow the companies to pool their resources at a time when mounting competition is forcing the industry to cut prices and provide a wider range of products.
As copies of drugs formerly under patent, generics have become a commodity in the US and elsewhere, and pharmaceutical companies must operate internationally, analysts said.
For Teva, based in Israel, and Ivax, based in Miami, the merger eliminates a large competitor and creates a supply chain that spans 50 countries. Last year, their combined revenues totaled about US$6.6 billion.
George Barrett, president and chief executive of Teva North America, described the deal as "a statement about our commitment to the industry."
As countries cope with rising health care costs, he said, they will increasingly turn to generic drugs to contain those costs.
"We want to be in the best possible position to satisfy that market," he said.
Under the terms of the deal, whose negotiations were reported on Monday in the New York Times, Ivax shareholders will receive either eight-tenths of a US depositary receipt representing Teva shares or US$26 in cash, a 14 percent premium over the stock's closing price on Friday of US$22.88. Ivax shareholders will then own about 15 percent of the combined company.
Manoj Garg, senior analyst at American Technology Research in Greenwich, Connecticut, said the industry's falling prices made growth difficult but vital.
"Generics is a business where size is a strategic advantage," he said, "and when these guys go to the wholesalers and retail pharmacies, there is value in being a single-source vendor."
A few other companies have taken the same approach. Novartis, the owner of Sandoz, which is currently the largest generic drug maker in the world, said in February that it would acquire Eon Labs for US$8.4 billion in cash. Mylan Laboratories, in Pittsburgh, tried to expand into brand-name drugs last year by buying King Pharmaceuticals for US$4 billion in stock, but it dropped the purchase after King restated some of its financial results.
Teva said that with its acquisition, its sales would exceed those of Sandoz.
Albert Rauch, a pharmaceutical analyst at AG Edwards in Chicago, said he expected more consolidation as profit margins continued to shrink. He pointed to Novartis as a possible acquirer and to Barr Laboratories, Watson Pharmaceuticals and Mylan Laboratories as both potential buyers and targets.
The government is aiming to recruit 1,096 foreign English teachers and teaching assistants this year, the Ministry of Education said yesterday. The foreign teachers would work closely with elementary and junior-high instructors to create and teach courses, ministry official Tsai Yi-ching (蔡宜靜) said. Together, they would create an immersive language environment, helping to motivate students while enhancing the skills of local teachers, she said. The ministry has since 2021 been recruiting foreign teachers through the Taiwan Foreign English Teacher Program, which offers placement, salary, housing and other benefits to eligible foreign teachers. Two centers serving northern and southern Taiwan assist in recruiting and training
WIDE NET: Health officials said they are considering all possibilities, such as bongkrekic acid, while the city mayor said they have not ruled out the possibility of a malicious act of poisoning Two people who dined at a restaurant in Taipei’s Far Eastern Department Store Xinyi A13 last week have died, while four are in intensive care, the Taipei Department of Health said yesterday. All of the outlets of Malaysian vegetarian restaurant franchise Polam Kopitiam have been ordered to close pending an investigation after 11 people became ill due to suspected food poisoning, city officials told a news conference in Taipei. The first fatality, a 39-year-old man who ate at the restaurant on Friday last week, died of kidney failure two days later at the city’s Mackay Memorial Hospital. A 66-year-old man who dined
EYE ON STRAIT: The US spending bill ‘doubles security cooperation funding for Taiwan,’ while also seeking to counter the influence of China US President Joe Biden on Saturday signed into law a US$1.2 trillion spending package that includes US$300 million in foreign military financing to Taiwan, as well as funding for Taipei-Washington cooperative projects. The US Congress early on Saturday overwhelmingly passed the Further Consolidated Appropriations Act 2024 to avoid a partial shutdown and fund the government through September for a fiscal year that began six months ago. Under the package, the Defense Appropriations Act would provide a US$27 billion increase from the previous fiscal year to fund “critical national defense efforts, including countering the PRC [People’s Republic of China],” according to a summary
‘CARRIER KILLERS’: The Tuo Chiang-class corvettes’ stealth capability means they have a radar cross-section as small as the size of a fishing boat, an analyst said President Tsai Ing-wen (蔡英文) yesterday presided over a ceremony at Yilan County’s Suao Harbor (蘇澳港), where the navy took delivery of two indigenous Tuo Chiang-class corvettes. The corvettes, An Chiang (安江) and Wan Chiang (萬江), along with the introduction of the coast guard’s third and fourth 4,000-tonne cutters earlier this month, are a testament to Taiwan’s shipbuilding capability and signify the nation’s resolve to defend democracy and freedom, Tsai said. The vessels are also the last two of six Tuo Chiang-class corvettes ordered from Lungteh Shipbuilding Co (龍德造船) by the navy, Tsai said. The first Tuo Chiang-class vessel delivered was Ta Chiang (塔江)